Pulse Biosciences
PLSE
72 hedge funds and large institutions have $98.4M invested in Pulse Biosciences in 2024 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 24 increasing their positions, 17 reducing their positions, and 3 closing their positions.
533% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 3
120% more call options, than puts
Call options by funds: $3.34M | Put options by funds: $1.52M
82% more capital invested
Capital invested by funds: $54.1M → $98.4M (+$44.4M)
41% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 17
26% more funds holding
Funds holding: 57 → 72 (+15)
0.41% more ownership
Funds ownership: 8.75% → 9.16% (+0.41%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$3.42M |
| 2 |
Charles Schwab
San Francisco,
California
|
+$1.66M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.54M |
| 4 |
State Street
Boston,
Massachusetts
|
+$1.19M |
| 5 |
Nuveen
Charlotte,
North Carolina
|
+$934K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$385K |
| 2 |
Jane Street
New York
|
-$263K |
| 3 |
Bank of New York Mellon
New York
|
-$180K |
| 4 |
II
Inspire Investing
Meridian,
Idaho
|
-$169K |
| 5 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$169K |
PLSE Hedge Fund Activity: Q3 2024 in Review
72 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in Pulse Biosciences (PLSE) for Q3 2024, worth a combined $98.4M — up 82% from $54.1M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new PLSE positions and 3 closed out — a net gain of 16 holders — while 24 added to existing stakes and 17 trimmed.
The largest buyer was BlackRock, adding an estimated $3.42M. The largest seller was Renaissance Technologies, cutting an estimated $385K.
- 72 institutional investors held Pulse Biosciences (PLSE) as of Q3 2024, up from 57 in Q2 2024.
- Funds reported $98.4M of Pulse Biosciences stock for Q3 2024, up 82% quarter-over-quarter.
- 19 funds opened new Pulse Biosciences positions in Q3 2024 and 3 closed out, a net change of +16 holders.
- The largest Pulse Biosciences buyer in Q3 2024 was BlackRock, an estimated $3.42M added.
- The largest Pulse Biosciences seller in Q3 2024 was Renaissance Technologies, an estimated $385K sold.
Based on aggregated 13F filings for Q3 2024.